Biofil Chemicals & Pharmaceuticals (BOM:524396) ROCE % : 2.51% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biofil Chemicals & Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.51%.

Biofil Chemicals & Pharmaceuticals ROCE % Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals ROCE % Chart

Biofil Chemicals & Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

5.66

11.11

12.64

6.26

4.79

Biofil Chemicals & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															3.30	7.53	7.58	3.60	2.51

Biofil Chemicals & Pharmaceuticals ROCE % Calculation

Biofil Chemicals & Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	8.355	/	( ( (187.322 - 14.947)	+	(314.057 - 137.255) )	/ 2 )
	=	8.355	/	( (172.375	+	176.802)	/ 2 )
	=	8.355	/	174.5885
	=	4.79 %

Biofil Chemicals & Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	4.536	/	( ( (422.162 - 241.671)	+	(0 - 0) )	/ 1 )
	=	4.536	/	( ( 180.491	+	0 )	/ 1 )
	=	4.536	/	180.491
	=	2.51 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Biofil Chemicals & Pharmaceuticals (BOM:524396) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biofil Chemicals & Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (BOM:524396) » Definitions » ROCE %

Traded in Other Exchanges

BIOFILCHEM:India

Address

11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015

Website

https://www.biofilgroup.net

Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Headlines

No Headlines